Related Experiment Video
Updated: Aug 6, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case-Control Study
Cady K Block1, Margi Patel2, Benjamin B Risk3,4
1Department of Neurology Emory University School of Medicine Atlanta Georgia USA.
Movement Disorders Clinical Practice
|March 23, 2023
Summary
Deep brain stimulation (DBS) offers significant motor benefits and medication reduction for Parkinson's disease (PD) patients with moderate cognitive impairment. This study shows comparable outcomes to those with normal cognition, challenging previous contraindications.
Area of Science:
- Neurology
- Neurosurgery
- Cognitive Science
Background:
- Deep brain stimulation (DBS) for Parkinson's disease (PD) is typically not recommended for patients with dementia.
- Current guidelines for DBS in PD are based on studies of patients with mild cognitive impairment or normal cognition.
Purpose of the Study:
- To evaluate the efficacy of DBS in Parkinson's disease patients with moderate cognitive impairment, including those with mild dementia.
- To assess both motor and non-motor outcomes in this patient cohort.
Main Methods:
- A retrospective case-control study involving 40 PD patients with moderate cognitive impairment (CI) and 40 matched PD patients with normal cognition (NC).
- Surgical targets included subthalamus, pallidus, or motor thalamus, with unilateral, bilateral, or staged approaches.
- Clinical outcomes were compared at 1-year follow-up.
Main Results:
- The CI cohort showed similar improvements in motor scores, motor fluctuations, and medication reduction compared to the NC cohort post-surgery.
- Both groups exhibited comparable rates of adverse events.
- Outcomes in the CI group were not influenced by the specific surgical target, staging, or the cognitive domain affected.
Conclusions:
- Parkinson's disease patients with moderate cognitive impairment can achieve significant motor benefits from DBS.
- DBS can lead to meaningful medication reduction in this population.
- These findings suggest that DBS may be a viable option for selected PD patients with cognitive impairment.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
321
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
321
Parkinson's Disease: Overview
633
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
633
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K

